MFSD2A (NLS1) (C-Terminus) (Cytoplasmic) Antibody - FFPE Validated

Scientific Overview

Bring MFSD2A C-Terminus (NLS1) into view to investigate changes across conditions. MFSD2A C-Terminus is a junctional protein that coordinates adhesion with cytoskeletal anchoring. Look for shifts in distribution that track with phenotype changes.

In some datasets and protocols, it is referenced by the gene symbol NLS1.

Research Relevance

Researchers often monitor junctional targets when studying epithelial integrity, remodeling, and motility. Pair measurements with orthogonal readouts when interpretation is sensitive to context.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood. Blood-brain barrier models often monitor junction regulation alongside permeability-focused measurements.

When building a narrative around the target, it helps to track:

• co-localization patterns with cytoskeletal elements
• comparative profiling across cell states or perturbations
• subcellular redistribution at contact sites versus cytoplasm
• changes in complex assembly with scaffold or adaptor proteins

Application-Specific Context

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so MFSD2A C-Terminus patterns can be compared across experiments without guesswork.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so MFSD2A C-Terminus patterns can be compared across experiments without guesswork.

With a clear focus on MFSD2A C-Terminus (NLS1), this fixed-section option fits streamlined studies and fast iteration.